Alembia Intellectual Property and its Partners are recommended in the 2020 edition of the IAM Patent 1000!

The UK Government will no longer seek to participate in the Unitary Patent or Unified Patent Court (UPC) system despite ratification of the agreement in 2018.

We are looking forward to presenting at North West Biotech Initiative's "Intellectual Property in the Life Sciences" event tomorrow evening, together with UMI3 from the University of Manchester.

The UK IPO have issued new guidance on intellectual property during the Brexit transition period.

All European patent eyes were turned to Munich this week, and the much anticipated EPO Board of Appeal hearing in The Broad Institute's CRISPR case. In news that surprised no European Patent Attorneys at all (!), the appeal was dismissed, The Broad Institute's priority claim was held to be invalid, and the patent was revoked.